Dynamic regulation of pituitary mRNAs for bone morphogenetic protein (BMP) 4, BMP receptors, and activin/inhibin subunits in the ewe during the estrous cycle and in cultured pituitary cells

Journal of Endocrinology

Volumn 207, Issue 1, 2010, Pages 55-65

  Sallon, C ^a,b,c,d   Faure, M O ^a,b,c,d   Fontaine, J ^a,b,c,d   Taragnat, C ^a,b,c,d  

^a CEMAGREF   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d Haras Nationaux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; ESTRADIOL; FOLLITROPIN BETA SUBUNIT; GESTAGEN; GONADORELIN; INHIBIN; INHIBITOR OF DIFFERENTIATION 2; MESSENGER RNA; NOGGIN; 1,3 DIOXOLANE DERIVATIVE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; BENZAMIDE DERIVATIVE; CARRIER PROTEIN; FOLLITROPIN; NOGGIN PROTEIN; PRIMER DNA; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ESTRUS CYCLE; EWE; FEMALE; FOLLITROPIN RELEASE; HORMONE BLOOD LEVEL; HYPOPHYSIS CELL; IMMUNOCOMPETENT CELL; LUTEAL PHASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; CHEMISTRY; DRUG EFFECTS; ESTRUS; GENETICS; HYPOPHYSIS; METABOLISM; PHYSIOLOGY; PROTEIN SUBUNIT; SECRETION (PROCESS); SHEEP; TRANSCRIPTION INITIATION;

ACTIVINS; ANIMALS; BASE SEQUENCE; BENZAMIDES; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS; CARRIER PROTEINS; CELLS, CULTURED; DIOXOLES; DNA PRIMERS; ESTRADIOL; ESTRUS; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GONADOTROPIN-RELEASING HORMONE; PITUITARY GLAND; PROTEIN SUBUNITS; RNA, MESSENGER; SHEEP; TRANSCRIPTIONAL ACTIVATION;

EID: 77957122220     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0035     Document Type: Article

References (45)

1. Allendorph GP, Vale WW & Choe S 2006 Structure of the ternary signaling complex of a TGF-β superfamily member. PNAS 103 7643-7648. (doi:10.1073/pnas.0602558103) (Pubitemid 43752834)
2. Attardi B, Keeping HS, Winters SJ, Kotsuji F & Troen P 1989 Effect of inhibin from primate Sertoli cells and GnRH on gonadotropin subunit mRNA in rat pituitary cell cultures. Molecular Endocrinology 3 1236-1242. (doi:10.1210/mend-3-8-1236)
3. Baratta M, West LA, Turzillo AM & Nett TM 2001 Activin modulates differential effects of estradiol on synthesis and secretion of follicle-stimulating hormone in ovine pituitary cells. Biology of Reproduction 64 714-719. (doi:10.1095/biolreprod64.2.714)
4. Bilezikjian LM, Blount AL, Leal AM, Donaldson CJ, Fischer WH & Vale WW 2004 Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Molecular and Cellular Endocrinology 225 29-36. (doi:10.1016/j.mce.2004.02.010)
5. Carroll RS, Corrigan AZ, Gharib SD, Vale W & Chin WW 1989 Inhibin, activin, and follistatin: regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Molecular Endocrinology 3 1969-1976. (doi:10.1210/mend-3-12-1969) (Pubitemid 20036902)
6. Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH & Vale W 1991 Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128 1682-1684. (doi:10.1210/endo-128-3-1682)
7. Dalkin AC, Haisenleder DJ, Gilrain JT, Aylor K, Yasin M & Marshall JC 1999 Gonadotropin-releasing hormone regulation of gonadotropin subunit gene expression in female rats: actions on follicle-stimulating hormone β messenger ribonucleic acid (mRNA) involve differential expression of pituitary activin (β-B) and follistatin mRNAs. Endocrinology 140 903-908. (doi:10.1210/en.140.2.903)
8. B subunit messenger ribonucleic acid levels in cultured rat pituitary: studies by a quantitative RT-PCR. Endocrine Journal 43 403-410. (doi:10.1507/endocrj.43.403)
9. DePaolo LV, Bald LN & Fendly BM 1992 Passive immunoneutralization with a monoclonal antibody reveals a role for endogenous activin-B in mediating FSH hypersecretion during estrus and following ovariectomy of hypophysectomized, pituitary-grafted rats. Endocrinology 130 1741-1743. (doi:10.1210/en.130.3. 1741)
10. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH & Miyazono K 1994 Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry 269 16985-16988.
11. Dupont J, McNeilly J, Vaiman A, Canepa S, Combarnous Y & Taragnat C 2003 Activin signaling pathways in ovine pituitary and LβT2 gonadotrope cells. Biology of Reproduction 68 1877-1887. (doi:10.1095/biolreprod.102.012005)
12. Fafioffe A, Ethier JF, Fontaine J, JeanPierre E, Taragnat C & Dupont J 2004 Activin and inhibin receptor gene expression in the ewe pituitary throughout the oestrous cycle. Journal of Endocrinology 182 55-68. (doi:10.1677/joe.0.1820055)
13. Faure MO, Nicol L, Fabre S, Fontaine J, Mohoric N, McNeilly A & Taragnat C 2005 BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary. Journal of Endocrinology 186 109-121. (doi:10.1677/joe.1.05988)
14. Halvorson LM, Weiss J, Bauer-Dantoin AC & Jameson JL 1994 Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle. Endocrinology 134 1247-1253. (doi:10.1210/en.134.3.1247) (Pubitemid 24085577)
15. Herrera B & Inman GJ 2009 A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biology 10 20. (doi:10.1186/1471-2121-10-20)
16. Ho CC & Bernard DJ 2009 Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone β subunit transcription. Biology of Reproduction 81 133-141. (doi:10.1095/biolreprod.108. 074211)
17. Huang HJ, Wu JC, Su P, Zhirnov O & Miller WL 2001 A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 142 2275-2283. (doi:10.1210/en.142.6.2275)
18. Kawabata M, Imamura T & Miyazono K 1998 Signal transduction by bone morphogenetic proteins. Cytokine and Growth Factor Reviews 9 49-61. (doi:10.1016/S1359-6101(97)00036-1)
19. Kogawa K, Nakamura T, Sugino K, Takio K, Titani K & Sugino H 1991 Activin-binding protein is present in pituitary. Endocrinology 128 1434-1440. (doi:10.1210/endo-128-3-1434)
20. de Kretser DM & Robertson DM 1989 The isolation and physiology of inhibin and related proteins. Biology of Reproduction 40 33-47. (doi:10.1095/biolreprod40.1.33)
21. Lee KB, Khivansara V, Santos MM, Lamba P, Yuen T, Sealfon SC & Bernard DJ 2007 Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone β subunit transcription. Journal of Molecular Endocrinology 38 315-330. (doi:10.1677/jme.1.02196) (Pubitemid 46351612)
22. Lerrant Y, Kottler ML, Bergametti F, Moumni M, Blumberg-Tick J & Counis R 1995 Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin β-subunit genes in normal and castrated rat pituitary. Endocrinology 136 2803-2808. (doi:10.1210/en.136.7.2803)
23. Leung K, Kim KE, Maurer RA & Landefeld TD 1988 Divergent changes in the concentrations of gonadotropin β-subunit messenger ribonucleic acid during the estrous cycle of sheep. Molecular Endocrinology 2 272-276. (doi:10.1210/mend-2-3-272)
24. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM & Vale W 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404 411-414. (doi:10.1038/35006129)
25. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M & Guillemin R 1986 A homodimer of the β-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochemical and Biophysical Research Communications 138 1129-1137. (doi:10.1016/S0006-291X(86)80400-4) (Pubitemid 16028517)
26. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M & Wrana JL 1998 Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. Journal of Biological Chemistry 273 25628-25636. (doi:10.1074/jbc.273.40. 25628)
27. Miller WL, Knight MM, Grimek HJ & Gorski J 1977 Estrogen regulation of follicle stimulating hormone in cell cultures of sheep pituitaries. Endocrinology 100 1306-1316. (doi:10.1210/endo-100-5-1306) (Pubitemid 8094050)
28. Miyazono K, Kusanagi K & Inoue H 2001 Divergence and convergence of TGF-β/BMP signaling. Journal of Cellular Physiology 187 265-276. (doi:10.1002/jcp.1080)
29. Miyazono K, Kamiya Y & Morikawa M 2010 Bone morphogenetic protein receptors and signal transduction. Journal of Biochemistry 147 35-51. (doi:10.1093/jb/mvp148)
30. Monniaux D, Clemente N, Touze JL, Belville C, Rico C, Bontoux M, Picard JY & Fabre S 2008 Intrafollicular steroids and anti-mullerian hormone during normal and cystic ovarian follicular development in the cow. Biology of Reproduction 79 387-396. (doi:10.1095/biolreprod.107.065847)
31. Morel G, Dubois P, Benassayag C, Nunez E, Radanyi C, Redeuilh G, Richard-Foy H & Baulieu EE 1981 Ultrastructural evidence of oestradiol receptor by immunochemistry. Experimental Cell Research 132 249-257. (doi:10.1016/0014-4827(81)90100-2)
32. Nicol L, Faure MO, McNeilly JR, Fontaine J, Taragnat C & McNeilly AS 2008 Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LβT2 gonadotrophs. Journal of Endocrinology 196 497-507. (doi:10.1677/JOE-07-0542)
33. Nudi M, Ouimette JF & Drouin J 2005 Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Molecular Endocrinology 19 1329-1342. (doi:10.1210/me.2004-0425) (Pubitemid 40594128)
34. Otsuka F & Shimasaki S 2002 A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143 4938-4941. (doi:10.1210/en.2002-220929)
35. Padmanabhan V & McNeilly AS 2001 Is there an FSH-releasing factor? Reproduction 121 21-30. (doi:10.1530/rep.0.1210021)
36. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST et al. 2003 Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. PNAS 100 1034-1039. (doi:10.1073/pnas. 0237312100)
37. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, Luu HH, Park JK, Li X, Luo J et al. 2004 Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. Journal of Biological Chemistry 279 32941-32949. (doi:10.1074/jbc.M403344200)
38. Shafiee-Kermani F, Han SO & Miller WL 2007 Chronic GnRH inhibits activin induction of the ovine FSH β subunit: involvement of cAMP response element binding protein (CREB) and nitric oxide synthase type I (NOSI). Endocrinology 148 3346-3355. (doi:10.1210/en.2006-1740)
39. Taragnat C, Bernier A & Fontaine J 1998 Gonadotrophin storage patterns in the ewe during the oestrous cycle or after long-term treatment with a GnRH agonist. Journal of Endocrinology 156 149-157. (doi:10.1677/joe.0. 1560149) (Pubitemid 28049874)
40. Uccella S, La Rosa S, Genasetti A & Capella C 2000 Localization of inhibin/activin subunits in normal pituitary and in pituitary adenomas. Pituitary 3 131-139. (doi:10.1023/A:1011431123208)
41. Vaughan JM, Rivier J, Corrigan AZ, McClintock R, Campen CA, Jolley D, Voglmayr JK, Bardin CW, Rivier C & Vale W 1989 Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods in Enzymology 168 588-617. (doi:10.1016/0076-6879(89)68044-5)
42. Wilson ME & Handa RJ 1998 Activin subunit, follistatin, and activin receptor gene expression in the prepubertal female rat pituitary. Biology of Reproduction 59 278-283. (doi:10.1095/biolreprod59.2.278)
43. Young JM, Juengel JL, Dodds KG, Laird M, Dearden PK, McNeilly AS, McNatty KP & Wilson T 2008 The activin receptor-like kinase 6 Booroola mutation enhances suppressive effects of bone morphogenetic protein 2 (BMP2), BMP4, BMP6 and growth and differentiation factor-9 on FSH release from ovine primary pituitary cell cultures. Journal of Endocrinology 196 251-261. (doi:10.1677/JOE-07-0148) (Pubitemid 351298510)
44. Yu PB, Beppu H, Kawai N, Li E & Bloch KD 2005 Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. Journal of Biological Chemistry 280 24443-24450. (doi:10.1074/jbc.M502825200)
45. Zwijsen A, Verschueren K & Huylebroeck D 2003 New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Letters 546 133-139. (doi:10.1016/S0014-5793(03)00566-0)